RAIA DROGASIL SA
Location
SAO PAULO
Founded
1935-03-28
Website
Risk Signals
715 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drug Stores and Proprietary Stores), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about RAIA DROGASIL SA
Live alerts from global media, monitored by Business Radar
2024-11-06 (spacemoney.com.br)
Raia Drogasil (RADL3) will repurchase up to 3.23 million shares
Program starts this Wednesday (6) and runs until May 6, 2026. It will allow the company to keep the shares acquired in treasury
Read more
2024-09-16 (dinheirama.com)
XP vê 3 actions to bet on this week
The shares of Transmissão Paulista (TRPL4), Raia Drogasil (RADL3) and BB Seguridade (BBSE3) were removed from the portfolio
Read more
2024-06-11 (acionista.com.br)
Raia Drogasil (RADL3) announces program to buy back up to 3.23 million shares
Raia Drogasil Logo – Website The board of directors of Raia Drogasil (RADL3) approved a new share buyback program. With the aim of reinforcing its Long-Term Incentive Program, which offers restricted shares to employees, the company will purchase up to 3.23 million of its own shares
Read more
2023-11-21 (portalvarada.com)
Brazilian stock exchange index registers increase
The stock exchange index returned to 125 thousand points
Read more
2023-08-09 (globo.com)
See what to do with Raia Drogasil shares after lower profit
Raia Drogasil released pressured results in the second quarter, but with strong revenue growth, says XP
Read more
2023-04-19 (globo.com)
Raia Drogasil approves capital increase in the amount of R$ 1.5 billion, with bonus shares to shareholders
Each shareholder will receive a bonus of 1 share for every 25 outstanding shares.
Read more
2023-04-05 (moneytimes.com.br)
10 stocks to invest in April, according to Guide
Guide Investimentos made two changes to its recommended stock portfolio for the month of April. Hypera (HYPE3) and PRIO (PRIO3) shares exit
Read more
2023-03-07 (globo.com)
Board of Raia Drogasil approves proposal that provides for a capital increase of R$ 1.5 billion
Transaction would be carried out through the capitalization of part of the profit reserve, with the issuance and distribution to shareholders of 66.08 million common shares
Read more
2022-11-29 (uol.com.br)
The Company - Profit of Raia Drogasil rises 30%, but shares fall in the year; worth investing?
This is part of the A Companhia newsletter, which analyzes whether or not it is time to buy Raia Drogasil shares and brings the company's positives and negatives.
Read more
2022-11-25 (panoramafarmaceutico.com.br)
Medicine against Covid only reaches pharmacies in 2023
Despite the intense repercussions after receiving approval from Anvisa, the first drug against Covid authorized by the agency should only reach pharmacies in 2023. Officially, Pfizer, the manufacturer of Paxlovid, guarantees that it is already working to bring the medicine to Brazil. However, the industry itself
Read more
2022-09-19 (acionista.com.br)
Focus reports that RD Ads closed a contract for the acquisition of eLoopz
Raia Drogasil announced that its subsidiary RD Ads Ltda entered into an Agreement for the Purchase and Sale of Shares and Other Covenants with the partners of eLoopz.
Read more
2022-06-06 (uol.com.br)
Raia Drogasil rises after JP Morgan buys more shares; worth it?
The shares of drugstore chain Raia Drogasil (RADL3) rose more than 2% today in the first half of this Monday's trading session (6).
Read more